AI achieves another breakthrough.

For some time now, AI has helped identify and crank through millions of molecular combinations. This is in order to locate potentially promising compounds for medical purposes. The latest development comes from an Anglo-Japanese research team. They devised an algorithm that performs this task on its own. The candidate compounds that emerge from the algorithm’s efforts still have to be tested in the laboratory. But the number of such candidates is much lower than had the research been done by humans. The reason is that the algorithm is substantially better than humans at weeding out compounds that are going to go nowhere. This has meant that the speed to human clinical trials for the algorithm’s compounds has fallen massively, from four and a half years to less than 12 months. AI drug design is just getting started.

Link to article:

You might also like to browse other AI articles: